Tuberculosis, Multidrug-Resistant
"Tuberculosis, Multidrug-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.
MeSH Number(s)
C01.252.410.040.552.846.775
Concept/Terms
Tuberculosis, Multidrug-Resistant- Tuberculosis, Multidrug-Resistant
- Multidrug-Resistant Tuberculosis
- Tuberculosis, Multidrug Resistant
- Tuberculosis, MDR
- MDR Tuberculosis
- Tuberculosis, Multi-Drug Resistant
- Multi-Drug Resistant Tuberculosis
- Tuberculosis, Multi Drug Resistant
Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Multidrug-Resistant".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Multidrug-Resistant".
This graph shows the total number of publications written about "Tuberculosis, Multidrug-Resistant" by people in Harvard Catalyst Profiles by year, and whether "Tuberculosis, Multidrug-Resistant" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 0 | 1 |
1996 | 3 | 2 | 5 |
1997 | 1 | 1 | 2 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 6 | 0 | 6 |
2001 | 5 | 1 | 6 |
2002 | 3 | 1 | 4 |
2003 | 7 | 0 | 7 |
2004 | 11 | 3 | 14 |
2005 | 11 | 2 | 13 |
2006 | 12 | 2 | 14 |
2007 | 10 | 2 | 12 |
2008 | 10 | 1 | 11 |
2009 | 9 | 1 | 10 |
2010 | 11 | 2 | 13 |
2011 | 18 | 3 | 21 |
2012 | 35 | 0 | 35 |
2013 | 30 | 2 | 32 |
2014 | 19 | 6 | 25 |
2015 | 24 | 0 | 24 |
2016 | 35 | 4 | 39 |
2017 | 26 | 3 | 29 |
2018 | 30 | 1 | 31 |
2019 | 21 | 4 | 25 |
2020 | 27 | 2 | 29 |
2021 | 32 | 0 | 32 |
2022 | 22 | 0 | 22 |
2023 | 19 | 0 | 19 |
2024 | 5 | 0 | 5 |
Below are the most recent publications written about "Tuberculosis, Multidrug-Resistant" by people in Profiles.
-
Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda. Lipids Health Dis. 2024 Mar 01; 23(1):65.
-
Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. Clin Infect Dis. 2024 Feb 17; 78(2):269-276.
-
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho. Glob Health Action. 2024 Dec 31; 17(1):2305930.
-
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs. Clin Infect Dis. 2024 Jan 25; 78(1):144-148.
-
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up. Clin Infect Dis. 2024 Jan 25; 78(1):164-171.
-
Burden of drug-resistant tuberculosis among contacts of index cases: a protocol for a systematic review. BMJ Open. 2024 01 09; 14(1):e074364.
-
Impacts of body weight change on treatment outcomes in patients with multidrug-resistant tuberculosis in Northwest Ethiopia. Sci Rep. 2024 01 04; 14(1):508.
-
Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India. PLoS One. 2023; 18(12):e0295508.
-
Cost of inaction: a framework to estimate the economic cost of missing a patient with tuberculosis in the Indian context. BMJ Open. 2023 12 20; 13(12):e070717.
-
Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis. Sci Rep. 2023 12 15; 13(1):22361.